NCT07027163View on ClinicalTrials.gov

A Study About the Use of Omalizumab in the Treatment of Food Allergy and Anaphylaxis

CompletedOBSERVATIONAL
Enrollment

62

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

September 1, 2023

Study Completion Date

September 1, 2023

Conditions
Food HypersensitivityAnaphylaxis
Trial Locations (1)

07936

Novartis, East Hanover

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY